Not FDA-approved
Digestive & weight
5-Amino-1MQ
Evidence
Limited human data
Class
Small-molecule NNMT inhibitor (not a peptide)
KEY TAKEAWAY
5-Amino-1MQ is a small molecule, not a peptide, that blocks an enzyme called NNMT. It is often sold alongside peptides as a fat-loss research chemical. 5-Amino-1MQ is not FDA-approved and has not been tested in controlled human trials.
Written by the Veylo editorial team · Updated
November 2026
What it is
Small-molecule NNMT inhibitor (not a peptide)
Main uses
Studied in animal models of obesity; sold online for fat loss
Key fact
5-Amino-1MQ is not FDA-approved and has not been tested in controlled human trials.
Route
Oral capsules sold online
Evidence strength
Limited human data
5-Amino-1MQ is a small molecule, not a peptide, that blocks an enzyme called NNMT. It is often sold alongside peptides as a fat-loss research chemical.
In mice, blocking NNMT in fat cells raised cellular energy use and reduced fat storage.
5-Amino-1MQ is not FDA-approved and has not been tested in controlled human trials.
Studied in animal models of obesity; sold online for fat loss.
Human safety data do not exist, and products sold online are not quality-checked.
5-Amino-1MQ: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.